Immunohistochemical stains for p63 and α-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: A comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues

American Journal of Surgical Pathology

Volumn 29, Issue 5, 2005, Pages 579-587

  Hameed, Omar ^a   Sublett, Jack ^a   Humphrey, Peter A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

methylacyl CoA racemase; Carcinoma; Immunohistochemistry; p63; Prostate

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ANTIBODY; PROTEIN P63; TUMOR MARKER;

ARTICLE; ATROPHY; CELL HYPERPLASIA; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; BIOPSY, NEEDLE; CELL NUCLEUS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MEMBRANE PROTEINS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 17744377621     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000157936.93999.18     Document Type: Article

References (33)

1. Amin MB, Tamboli P, Varma M, et al. Postatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens. Am J Surg Pathol. 1999;23:925-931.
2. Beach R, Gown AM, De Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588-1596.
3. Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993;24:819-832.
4. Browne TJ, Hirsch MS, Brodsky G, et al. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Hum Pathol. 2004;35:1462-1468.
5. Epstein JI. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol. 1995;26:223-229.
6. Epstein JI, Grignon DJ, Humphrey PA, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol. 1995;19:873-886.
7. Farinola MA, Epstein JI. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol. 2004;35:1272-1278.
8. Gaudin PB, Epstein JI. Adenosis of the prostate: histologic features in needle biopsy specimens. Am J Surg Pathol. 1995;19:737-747.
9. Gaudin PB, Reuter VE. Benign mimics of prostatic adenocarcinoma on needle biopsy. Anat Pathol. 1997;2:111-134.
10. Humphrey PA. Prostate Pathology. Chicago: ASCP Press, 2003.
11. Jiang Z, Iczkowski KA, Woda BA, et al. P504S immunostaining boosts diagnostic resolution of 'suspicious' foci in prostatic needle biopsy specimens. Am J Clin Pathol. 2004;121:99-107.
12. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.
13. Jiang Z, Woda BA, Wu CL, et al. Discovery and clinical application of a novel prostate tumor marker: α-methylacyl racemase (P504S). Am J Clin Pathol. 2004;122:275-289.
14. Jiang Z, Wu CL, Woda BA, et al. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169-1174.
15. Jiang Z, Wu CL, Woda BA, et al. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology. 2004;45:218-225.
16. Kunju LP, Rubin MA, Chinnaiyan AM, et al. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations. Am J Clin Pathol. 2003;120:737-745.
17. Luo J, Zha S, Gage WR, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res. 2002;62:2220-2226.
18. Molinie V, Fromont G, Sibony M, et al. Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Mod Pathol. 2004;17:1180-1190.
19. Sackett DL, Haynes RB, Tugwell P, et al. The clinical examination. In: Sackett DL, Haynes RB, Tugwell P, et al, eds. Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1991:30.
20. Sanderson SO, Sebo TJ, Murphy LM, et al. An analysis of the p63/a-methylacyl coenzyme a racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. Am J Clin Pathol. 2004;121:220-225.
21. Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26:1161-1168.
22. Srigley JR. Benign mimickers of prostatic adenocarcinoma. Mod Pathol. 2004;17:328-348.
23. Thorson P, Humphrey PA. Minimal adenocarcinoma in prostate needle biopsy tissue. Am J Clin Pathol. 2000;114:896-909.
24. Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol. 2002;15:1302-1308.
25. Wu CL, Yang XJ, Tretiakova M, et al. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol. 2004;35:1008-1013.
26. Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000;60:1677-1682.
27. Yang XJ, Tretiakova MS, Sengupta E, et al. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis. Hum Pathol. 2003;34:462-470.
28. Yang XJ, Wu CL, Woda BA, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26:921-925.
29. Young RH. Pseudoneoplastic lesions of the urinary bladder, prostate gland and urethra. In: Wick MR, Humphrey PA, Ritter JH, eds. Pathology of Pseudoneoplastic Lesions. Philadelphia: Lippincott-Raven, 1997:209-245.
30. Zhou M, Aydin H, Kanane H, et al. How often does alpha-methylacyl-CoA- racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol. 2004;28:239-243.
31. Zhou M, Chinnaiyan AM, Kleer CG, et al. Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol. 2002;26:926-931.
32. Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol. 2003;27:772-778.
33. Zhou M, Shah R, Shen R, et al. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells. Am J Surg Pathol. 2003;27:365-371.